LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas

Anaplastic glioma is Grade III and the median overall survival is about 37.6 months. However, there are still other factors that affect the prognosis for anaplastic glioma patients due to variable overall survival. So we screened four-lncRNA signature (AGAP2-AS1, TPT1-AS1, LINC01198 and MIR155HG) fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen, Yang, Fan, Zhang, Lu, Chen, Jing, Zhao, Zheng, Wang, Haoyuan, Wu, Fan, Liang, Tingyu, Yan, Xiaoyan, Li, Jiye, Lan, Qing, Wang, Jiangfei, Zhao, Jizong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363582/
https://www.ncbi.nlm.nih.gov/pubmed/27764782
http://dx.doi.org/10.18632/oncotarget.12624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363582/
https://www.ncbi.nlm.nih.gov/pubmed/27764782
http://dx.doi.org/10.18632/oncotarget.12624

Ejemplares similares